Goethe University is a university located in Frankfurt am Main, Germany. It was founded in 1914 as a citizens' university, which means it was founded and funded by the wealthy and active liberal citizenry of Frankfurt. The original name was Universität Frankfurt am Main.

During the past decade, Johann-Wolfgang-Goethe Universität conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johann-Wolfgang-Goethe Universität" #1 sponsor was "Eisai Inc." with 2 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Johannes Gutenberg University Mainz" with 2 trials sponsored and "Technische Universität Dresden" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johann-Wolfgang-Goethe Universität" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Goethe University" with 2 trials as a collaborator and "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Johann-Wolfgang-Goethe Universität" are "Acute Myeloid Leukemia" (3 trials), "HIV Infections" (2 trials), "Leukemia, Myelocytic, Acute" (2 trials), "Liver Metastases" (2 trials) and "Lymphoma, T-Cell, Cutaneous" (2 trials). Many other conditions were trialed in "Johann-Wolfgang-Goethe Universität" in a lesser frequency.

Most popular intervention types in "Johann-Wolfgang-Goethe Universität" are "Drug" (28 trials), "Device" (5 trials), "Procedure" (3 trials), "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Decitabine" (2 trials), "ONTAK" (2 trials), "Placebo" (2 trials), "2N(t)RTI" (1 trials) and "ACURATE neo™ Aortic Bioprosthesis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Johann-Wolfgang-Goethe Universität" are 38 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Johann-Wolfgang-Goethe Universität". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Johann-Wolfgang-Goethe Universität, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Johann-Wolfgang-Goethe Universität, 7 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".

Johann-Wolfgang-Goethe Universität has several departments that took part in Clinical trials: "Department of Neurology, University of Frankfurt" - 2 trials